Vanguard Group’s Neuraxis NRXS Stock Holding History
Bought
Maintained
Sold
Other funds holding NRXS
ACM
RA
MCC
PC
PCM
Vanguard Group's NRXS Position: Q4 2025 in Review
Vanguard Group increased its Neuraxis (NRXS) stake by 103% in Q4 2025, buying an estimated $221K and bringing the position to 145,562 shares worth $661K. The position accounts for ﹤0.01% of the portfolio, ranked #3881.
Vanguard Group first reported a position in NRXS in Q4 2023 and has held it in 9 quarters since. 18 funds tracked by Wall St. Rank hold NRXS as of Q4 2025.
- Vanguard Group held 145,562 shares of Neuraxis worth $661K as of Q4 2025.
- Vanguard Group bought 73,930 Neuraxis shares in Q4 2025, an estimated $221K.
- Neuraxis made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3881 holding.
- Vanguard Group first reported a position in Neuraxis in Q4 2023 and has held it in 9 quarters since.
- 18 funds tracked by Wall St. Rank held Neuraxis as of Q4 2025.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.